PR-LncRNA Signature Regulates Glioma Cell Activity Through Expression of SOX Factors
dc.contributor.author | Torres Bayona, Sergio Andrés | |
dc.contributor.author | Aldaz Donamaría, Paula | |
dc.contributor.author | Auzmendi Iriarte, Jaione | |
dc.contributor.author | Sáenz Antoñanzas, Ander | |
dc.contributor.author | García Camino, Idoia | |
dc.contributor.author | Arrazola Schlamilch, Mariano | |
dc.contributor.author | Gerovska, Daniela | |
dc.contributor.author | Undabeitia Huertas, José | |
dc.contributor.author | Querejeta Ayerra, Arrate | |
dc.contributor.author | Egaña Otaño, Larraitz | |
dc.contributor.author | Villanua Bernues, Jorge Alberto | |
dc.contributor.author | Ruiz Díaz, Irune | |
dc.contributor.author | Sarasqueta Eizaguirre, Cristina | |
dc.contributor.author | Urculo Bareño, Enrique | |
dc.contributor.author | Araúzo Bravo, Marcos J. | |
dc.contributor.author | Huarte Martínez, Maite | |
dc.contributor.author | Samprón Lebed, Nicolás | |
dc.contributor.author | Matheu Fernández, Ander | |
dc.date.accessioned | 2018-12-12T13:12:39Z | |
dc.date.available | 2018-12-12T13:12:39Z | |
dc.date.issued | 2018-08-24 | |
dc.identifier.citation | Scientific Reports 8 : (2018) // Article ID 12746 | es_ES |
dc.identifier.issn | 2045-2322 | |
dc.identifier.uri | http://hdl.handle.net/10810/30289 | |
dc.description.abstract | Long non-coding RNAs (LncRNAs) have emerged as a relevant class of genome regulators involved in a broad range of biological processes and with important roles in tumor initiation and malignant progression. We have previously identified a p53-regulated tumor suppressor signature of LncRNAs (PR-LncRNAs) in colorectal cancer. Our aim was to identify the expression and function of this signature in gliomas. We found that the expression of the four PR-LncRNAs tested was high in human low-grade glioma samples and diminished with increasing grade of disease, being the lowest in glioblastoma samples. Functional assays demonstrated that PR-LncRNA silencing increased glioma cell proliferation and oncosphere formation. Mechanistically, we found an inverse correlation between PR-LncRNA expression and SOX1, SOX2 and SOX9 stem cell factors in human glioma biopsies and in glioma cells in vitro. Moreover, knock-down of SOX activity abolished the effect of PR-LncRNA silencing in glioma cell activity. In conclusion, our results demonstrate that the expression and function of PR-LncRNAs are significantly altered in gliomagenesis and that their activity is mediated by SOX factors. These results may provide important insights into the mechanisms responsible for glioblastoma pathogenesis. | es_ES |
dc.description.sponsorship | PA, JA-I and AS-A were recipients of a predoctoral fellowship from the Spanish Association Against Cancer (AECC Gipuzkoa), Basque Government and Instituto Salud Carlos III. This work was supported by grants from the Carlos III Institute of Health and the European Regional Development Fund (PI13/02277, CP16/00039, DTS16/084, and PI16/01580) and Industry and Health Departments of the Basque Country. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Nature Publishing Group | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.subject | long noncoding RNAs | es_ES |
dc.subject | adjuvant temozolomide | es_ES |
dc.subject | transcription factors | es_ES |
dc.subject | glioblastoma | es_ES |
dc.subject | STEM | es_ES |
dc.subject | cancer | es_ES |
dc.subject | radiotherapy | es_ES |
dc.subject | pathogenesis | es_ES |
dc.subject | concomitant | es_ES |
dc.subject | inhibition | es_ES |
dc.title | PR-LncRNA Signature Regulates Glioma Cell Activity Through Expression of SOX Factors | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. | es_ES |
dc.rights.holder | Atribución 3.0 España | * |
dc.relation.publisherversion | https://www.nature.com/articles/s41598-018-30836-5 | es_ES |
dc.identifier.doi | 10.1038/s41598-018-30836-5 | |
dc.departamentoes | Cirugía, radiología y medicina física | es_ES |
dc.departamentoes | Dermatología, oftalmología y otorrinolaringología | es_ES |
dc.departamentoeu | Dermatologia, oftalmologia eta otorrinolaringologia | es_ES |
dc.departamentoeu | Kirurgia,erradiologia eta medikuntza fisikoa | es_ES |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.